Access cutting-edge chondrosarcoma treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.
Access chondrosarcoma specialists in New Haven at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chondrosarcoma treatment provided free
Randomized, blinded, placebo-controlled, Phase 2 study of INBRX-109 in unresectable or metastatic conventional chondrosarcoma patients.
Sponsor: Inhibrx Biosciences, Inc
Check if you qualify for this chondrosarcoma clinical trial in New Haven, CT
If you're searching for chondrosarcoma treatment options in New Haven, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chondrosarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.